IG Has Overly “Negative” View Of Sales Incentives, Pfizer Counsel Says

The HHS Inspector General's draft compliance guidance for the pharmaceutical industry takes an overly "negative" stance on compensation for sales representatives, Pfizer Corporate Compliance Counsel Doug Lankler said